ClosedHealth & Human Services
Ensuring Research Integrity - Research, Development, and Demonstration
Office of the Assistant Secretary for HealthIR-ORI-23-001
Description
The Office of Research Integrity (ORI) announces the anticipated availability of funds for Fiscal Year (FY) 2023 grant awards under the authority of Sec. 301 of the Public Health Service Act, 42 U.S.C. § 241. ORI seeks projects that will: 1) conduct research, on one of the four focus areas identified below, related to ensuring research integrity and compliance with 42 C.F.R. Part 93; 2) develop innovative approaches/tools/resources based on the results of this research; and 3) demonstrate the impact and/or effectiveness of these approaches/tools/resources. The purpose of this initiative is to provide assistance to recipients to promote the integrity and reliability of PHS-funded research through the development and implementation of innovative practical approaches/tools/resources that improve practices related to one of the following four focus areas: 1) transparency in the reporting of research; 2) effective communication between authors/collaborators for the purpose of avoiding, mitigating, and resolving authorship/collaborator disputes and/or issues related to the integrity of the research (e.g. conflicts of interest, research integrity, rigor, reproducibility, transparency, reliability); 3) handling allegations of research misconduct under 42 C.F.R. Part 93; or 4) interventions to address issues related to research culture and climate (e.g., ultra-competitive environments, toxic workplaces, bullying, harassment, etc.) that can negatively impact the integrity, conduct, quality, and reliability of research. ORI expects that approaches/tools/resources developed through this funding opportunity will be disseminated to and made freely available for use by the PHS-funded research community. This funding opportunity does not support projects with the primary purpose of holding meetings, conferences, or workshops (see opportunity IR-ORI-23-002). ORI anticipates making awards of between $75,000 and $150,000 in total federal share (direct plus indirect) per year, for a project period not to exceed two years (two 12-month budget periods). Recipients will be required to submit a non-competing application for any budget period after the first. (Budget periods are typically 12 months). Continuation award funding will be contingent upon availability of funding, satisfactory performance (including awardee progress towards meeting stated project milestones goals, timely submission of required reports, and compliance with all grant terms and conditions), and the best interests of the government.
Award Ceiling
$150K
Award Floor
$75K
Total Funding
$450K
CFDA Number
93.085
Funding Instrument
Grant
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
March 1, 2023
Close Date
May 10, 2023
Posted Date
March 1, 2023
Eligible Applicant Types
Special district governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationSmall businessesPublic housing authorities/Indian housing authoritiesCity or township governmentsNative American tribal organizations (other than Federally recognized tribal governments)Public and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Independent school districtsCounty governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationIndividualsState governmentsUnrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"For profit organizations other than small businesses
Tags
HHS-OPHSCFDA:93.085GrantEducationScience and Technology and other Research and Development
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left